joreth: (Silent Bob Headbang)
Merk's competitor, GlaxoSmithKline has received approval for their rival HPV vaccine, Cervarix.  This is a good thing.  This is where the "free market" and "capitalism" has a place in medicine - the competition should, hopefully, drive consumer prices down to a more affordable and reasonable rate, for those of us without insurance or beyond the approved age limit for insurance coverage.

http://www.reuters.com/article/pressRelease/idUS158707+16-Oct-2009+PRN20091016

Date: 10/19/09 04:27 am (UTC)From: [identity profile] greenfizzpops.livejournal.com
In South Africa, where both vaccines were approved roughly at the same time, Cervarix is about R500 a dose while Gardasil is about R900 a dose.

Banners